Chat message
Slack / Private Message Drop, pp.356-357 [SLACK_000570] · slack_pm:msg:03730
Page text: p.356, p.357 · original PDF
- Date
- 2021-01-04 09:00
- Type
- chat message · slack
- recipient
- Kristian G. Andersen, Robert F. Garry, Edward C. Holmes
- speaker
- Andrew Rambaut
Recipients on this medium are inferred from channel membership, not per-message addressing.
Just sent to Bob and me (plus Christian Drosten, Trevor and Guy Hoelzer).
```Gentlemen,
It appears that the mutations in the spike protein that causes PCR failure for that part of the Taqpath assay will befound to have induced a PCR selection bias, and thus contributed to the spread of the virus without increasedpathogenicity.Specifically, there will be more false negatives in tests of people with any variant with new variation in the primer target sequences, especially the 8 variants Andrew reported in the spike protein coding region. The reported PCRprobe failure in the S gene assures biased transmission of the virus since testing results in self-quarantine. This seems necessarily so given the diagnostic interpretive algorithm in use with Taqpath, the '2 or greater"algorithm, any single probe failure due to mistargeting will increase the probability of a failed PCR test overall given the sum baseline rate of failure of both of the other two probes.See p 104. https://www.fda.gov/media/136112/downloadIt should be straightforward and therefore I propose modeling and simulation to calculate the expected rate of test escape and selection due to mutations in any of the primer sites to distinguish pathogenic variants from those being selected by testing bias.I expect the results will show that test kits will have to be updated to keep up with RNA virus evolution. Free free to and please send any related material or draft analyses for friendly-fire review. I'm also of course interested in any variation associated with severe COVID19 or long-haul COVID19.I encourage working immunogenicity predictions into analyses interpretive of genetic variants as well. We can ofcourse expect evolution away from the vaccine type and from the more immunogenic types, which likely will cause more severe COVID19 as well asevolution away from human aa sequences due to increased risk of pathogenic priming due to autoreactive antibody production. Given these vectors, a path ofSARS-CoV-2 evolution might be mapped.Please reply-all for the favor of broad illumination.Also, should any of you care to discuss SARS-CoV-2 evolution on Unbreaking Science, contactSincerely,James Lyons-WeilerPS Re: origins: Check out HKU-3-3 - it appears to have SARS-CoV-2 -like functional motifs, but was published in2005/ Baric downloaded it in 2008. Both the original report and his people thought it was SARS. See second report here HKU-3-3 is a SARS-CoV-2 precusor, at least from the perspective of the spike protein.http://ipaknowledge.org/covid-19-and-sars-cov-2-research.phpAlso available herehttps://www.researchgate.net/publication/340769150_Motif_Pathogenicity_Typing_SARS-CoV-2_Coronavirus_May_Contain_a_Unique_Likely_Pathogenic_Protein_Motif_Signature_Also_Found_in_a_Natural_Isolate_from_2005```
Links shared
- gov https://www.fda.gov/media/136112/downloadIt
- other http://ipaknowledge.org/covid-19-and-sars-cov-2-research.phpAlso
- other https://www.researchgate.net/publication/340769150_Motif_Pathogenicity_Typing_SARS-CoV-2_Coronavirus_May_Contain_a_Unique_Likely_Pathogenic_Protein_Motif_Signature_Also_Found_in_a_Natural_Isolate_from_2005```